Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Gut|June 22, 2012
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitisPaul J Rutgeerts, Richard N Fedorak, Daan W Hommes, et al.
Scientific Reports|March 11, 2025
Relating the molecular phenotype of ulcerative colitis to the clinical courseKatelynn S Madill-Thomsen, Jeffery M Venner, Denise E Parsons, et al.
Cytotherapy|February 6, 2018
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017Rachele Ciccocioppo, Claudia C Dos Santos, Daniel C Baumgart, et al.
Digestive Diseases and Sciences|March 17, 2025
Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort StudyLisa M A van Lierop, Larissa Albino, Ryan Rosentreter, et al.
Scandinavian Journal of Gastroenterology|March 8, 2018
Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitisAxel Dignass, Ayesha Akbar, Daniel C Baumgart, et al.
Alimentary Pharmacology & Therapeutics|October 8, 2016
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational studyA Stallmach, C Langbein, R Atreya, et al.
Lancet (London, England)|August 2, 2016
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Inflammatory Bowel Diseases|December 20, 2007
No association of the CARD8 (TUCAN) c.30T>A (p.C10X) variant with Crohn's disease: a study in 3 independent European cohortsCarsten Büning, Hartmut H-J Schmidt, Tamás Molnár, et al.
Therapeutic Advances in Gastroenterology|October 3, 2022
A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel diseaseFarhad Peerani, Makayla Watt, Kathleen P Ismond, et al.
Journal of the Canadian Association of Gastroenterology|December 5, 2022
Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort StudyCynthia H Seow, Stephanie Coward, Karen I Kroeker, et al.
Pageof 15